Polyphenol Composition for Thermogenesis Without Caffeine Side Effects
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments for overweight and obesity, such as coffee and tea, are unsatisfactory due to the difficulty in controlling caffeine dosage, which can lead to cardiovascular issues and liver dysfunction, and there is a need for compounds that stimulate thermogenesis without the disadvantages of lipolysis.
Innovation Solution
A composition comprising edible extracts of Nelumbo nucifera, Mangifera indica, Acacia catechu, Commiphora mukul, Daucus carota, Cinnamomum verum, and Rosa canina, or combinations thereof, which are formulated into various forms to modulate adipose tissue metabolism, including thermogenesis, lipolysis, and adipogenesis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If caffeine is used to stimulate lipolysis and adipocyte metabolism, then thermogenesis and fat breakdown are enhanced, but cardiovascular health deteriorates and liver dysfunction occurs
Solution Approach 1:
The patent extracts and utilizes polyphenolic compounds (such as catechins, flavonoids, and tannins) from plant sources like green tea, coffee, and other botanicals, separating these beneficial compounds from the harmful caffeine component. This allows the composition to achieve fat metabolism stimulation through polyphenols while avoiding caffeine-induced cardiovascular and liver damage.
Solution Approach 2:
The patent introduces polyphenolic compounds as intermediary substances that mediate fat metabolism through alternative pathways. These polyphenols act as mediators that can stimulate lipolysis and thermogenesis through antioxidant mechanisms and enzyme modulation, bypassing the need for caffeine's direct adenosine receptor antagonism that causes harmful side effects.
2Productivity
If caffeine dosage is increased to enhance thermogenesis, then fat metabolism is improved, but dosage control becomes difficult and adverse effects increase
Solution Approach 1:
The patent changes the active ingredient parameter from caffeine to polyphenolic compounds, which have different pharmacokinetic properties. Polyphenols can be dosed more precisely and have lower toxicity thresholds, allowing for accurate dosage formulation. The composition specifies ranges of polyphenolic content (e.g., 50-500 mg per serving) that can be precisely controlled during manufacturing while achieving effective thermogenesis.
3Productivity
If lipolysis is stimulated to release fat from adipocytes, then weight loss is promoted, but cardiovascular problems and liver dysfunction are caused
Solution Approach 1:
The patent converts the potentially harmful rapid fat mobilization effect of caffeine into a beneficial controlled process using polyphenols. Polyphenolic compounds stimulate lipolysis more gradually and through different mechanisms (such as activating AMP-activated protein kinase and modulating hormone-sensitive lipase), which releases fat into the bloodstream in a controlled manner that does not overwhelm cardiovascular or hepatic systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively manages body weight by promoting thermogenesis and inhibiting adipogenesis, without the adverse effects of caffeine, and is suitable for various food and pharmaceutical applications.
Implementation Method 1
In thermogenesis, adipocytes convert fat directly into heat. More generally, thermogenesis is the production of heat in the human body by increasing cellular metabolism.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention relates to a composition comprising an edible extract of at least two of the plants selected from the group consisting of Acacia catechu, Daucus carota, Rosa canina, and Helichrysum italicum. The composition and the products derived therefrom are modulators of adipose tissue or fat burners, in particular by targeted activation of thermogenesis in a human or animal subject.